MedTrace Logo

A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes

NCT04667182 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-09-17

No results posted yet for this study

Summary

The main purpose of this study is to determine whether combining meal, glucose and insulin data in a web-based system will improve management of type 1 (T1D) and type 2 diabetes (T2D). No study drug will be given. The study will last about 18 weeks.

Conditions

Interventions

OTHER

Meal-Tagging App and Web-based Portal:

Meal tagging app to capture frequently eaten meals and test meals for 18 weeks.

DEVICE

Fitness Tracker

Fitness tracker will be worn around the clock for 18 weeks.

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2021-12-06
Completion
2021-12-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04667182 on ClinicalTrials.gov